Abstract
BackgroundThe leishmaniases are neglected and poorly reported diseases with underestimated or undetermined incidence in most countries of the WHO European Region. Since the late 1940s, the traditional drugs for VL...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
